Home The Word Brain	My Amedeo FAQ Privacy About
	Explore this week’s CC Journal Club 90‑sec video • 4‑min audio • paper abstracts

HIV Infection

Free Subscription 03.03.2025 13 AIDS 1 Clin Infect Dis 5 HIV Med 4 J Acquir Immune Defic Syndr 1 J Med Virol 2 J Virol 2 JAMA 1 Lancet 2 Nature 1 PLoS Comput Biol 7 PLoS One 1 Virology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AIDS

1. TAM C, Zhang W, Moore D, Salters K, et al
   Impacts of overdose and socio-structural factors on recent mortality among people living with HIV in British Columbia, Canada.
   AIDS. 2025 Feb 24. doi: 10.1097/QAD.0000000000004158.
   PubMed         Abstract available
   
   
2. WHELTON SP, Haberlen SA, Zhang L, Herrschaft R, et al
   Associations between HIV serostatus and coronary artery plaque volume progression.
   AIDS. 2025 Feb 25. doi: 10.1097/QAD.0000000000004165.
   PubMed         Abstract available
   
   
3. NAJJUUKO C, Brathwaite R, Xu Z, Kizito S, et al
   Using machine learning to predict poor adherence to antiretroviral therapy among adolescents living with HIV in low resource settings.
   AIDS. 2025 Feb 25. doi: 10.1097/QAD.0000000000004163.
   PubMed         Abstract available
   
   
4. KUHN L, Thomas P
   Studies of young adults with perinatal HIV infection provide new clues for HIV cure.
   AIDS. 2025;39:457-458.
   PubMed        
   
   
5. SHORT WR, Rakhmanina N
   Expanding choices of antiretroviral treatment regimens for pregnant and breastfeeding persons with HIV.
   AIDS. 2025;39:459-461.
   PubMed        
   
   
6. BARBER TJ, Gonzalez-Scarano F, Vance DE
   Cognitive dysfunction in people with HIV: the potential effect of personal and environmental circumstances.
   AIDS. 2025;39:462-463.
   PubMed        
   
   
7. COHN SE
   Women with HIV: increased need for reproductive health services to improve health outcomes.
   AIDS. 2025;39:464-466.
   PubMed        
   
   
8. GOODKIN K
   Sleep in the context of neuropsychiatric and primary medical comorbidity patterns among people with HIV.
   AIDS. 2025;39:467-469.
   PubMed        
   
   
9. BABALOLA CM, Peters RPH, Muzny CA, Davey DJ, et al
   From pregnancy to beyond: renewed emphasis on comprehensive HIV prevention in South Africa.
   AIDS. 2025;39:470-474.
   PubMed         Abstract available
   
   
10. MUCCINI C, Spagnuolo V, Zazzi M, Castagna A, et al
    People with four-class drug-resistant HIV-1 may have low levels of intact DNA.
    AIDS. 2025;39:475-476.
    PubMed         Abstract available
    
    
11. BELLOMO M, Gianotti N, Hasson H, Canetti D, et al
    Doravirine associated with greater LDL cholesterol reduction in people with HIV switching antiretroviral regimens.
    AIDS. 2025;39:477-479.
    PubMed         Abstract available
    
    
12. DAUNGSUPAWONG H, Wiwanitkit V
    Characterization of the genomic landscape of HIV-associated lymphoma.
    AIDS. 2025;39:480.
    PubMed        
    
    
13. SORENSEN EF, Hybel TE, Ludvigsen M
    Response to correspondence piece on 'Characterization of the genomic landscape of HIV-associated lymphoma reveals heterogeneity across histological subtypes'.
    AIDS. 2025;39:481.
    PubMed        
    
    

    
    Clin Infect Dis

14. VAN SICKELS N, Wong JWH, Villacorta-Cari E, Lee SE, et al
    State-of-the-Art Review: Data and Trust to Improve Care for Transgender and Gender-Diverse Patients.
    Clin Infect Dis. 2025;80:e16-e30.
    PubMed         Abstract available
    
    

    
    HIV Med

15. GIFFORD AJ, Jaspal R, Jones BA, McDermott DT, et al
    Predicting PrEP acceptability and self-efficacy among men who have sex with men in the UK: The roles of identity resilience, science mistrust, and stigma.
    HIV Med. 2025 Feb 27. doi: 10.1111/hiv.13768.
    PubMed         Abstract available
    
    
16. HENDERSON M, Lyons D, Beddows S, Cowen M, et al
    High-risk human papillomavirus prevalence and serostatus in a cohort of cisgender women and people with a cervix living with perinatally acquired HIV.
    HIV Med. 2025 Feb 25. doi: 10.1111/hiv.70001.
    PubMed         Abstract available
    
    
17. BEGUELIN C, Surial B, Hofmann E, Begre L, et al
    Frequent hepatitis B surface antigen (HBsAg) clearance during tenofovir therapy in persons with HIV/hepatitis B virus coinfection.
    HIV Med. 2025 Feb 25. doi: 10.1111/hiv.13766.
    PubMed         Abstract available
    
    
18. BLANCH J, Martinez E, Mena A, Duenas C, et al
    Impact of training healthcare professionals in the detection and management of neuropsychiatric comorbidities in people with HIV: The CONECTAR project in Spain.
    HIV Med. 2025 Feb 24. doi: 10.1111/hiv.70002.
    PubMed         Abstract available
    
    
19. ELKHEIR N, Dominic C, Price A, Carter J, et al
    HIV in Latin American migrants in the UK: A neglected population in the 95-95-95 targets.
    HIV Med. 2025 Feb 24. doi: 10.1111/hiv.70007.
    PubMed         Abstract available
    
    

    
    J Acquir Immune Defic Syndr

20. SCONZA R, Fernandes G, Bailey H, Peters H, et al
    Outcomes following prenatal exposure to raltegravir-containing antiretroviral therapy: a multi-cohort European study.
    J Acquir Immune Defic Syndr. 2025 Feb 25. doi: 10.1097/QAI.0000000000003645.
    PubMed         Abstract available
    
    
21. PUTHANAKIT T, Aurpibul L, Lopez M, Wang M, et al
    Efficacy and Safety of the Two-Drug Regimen Dolutegravir/Lamivudine in Adolescents Living With HIV-1 Naive to Antiretroviral Therapy at 48 Weeks (DANCE): A Single-Arm, Open-label, Phase 3b Trial.
    J Acquir Immune Defic Syndr. 2025 Feb 24. doi: 10.1097/QAI.0000000000003655.
    PubMed         Abstract available
    
    
22. VINOGRADOV V, Lee YG, Zhakupova G, Mergenova G, et al
    Social Impacts of Multi-City HIV Research Participation Among Sexual and Gender Expansive Individuals in Kazakhstan.
    J Acquir Immune Defic Syndr. 2025 Feb 24. doi: 10.1097/QAI.0000000000003654.
    PubMed         Abstract available
    
    
23. MBENGERANWA T, Ziemba L, Brummel SS, Johnston B, et al
    Bone mineral content, growth, and renal health of infants with perinatal exposure to maternal dolutegravir vs efavirenz and tenofovir disoproxil fumarate vs tenofovir alafenamide: the randomized IMPAACT 2010 (VESTED) trial.
    J Acquir Immune Defic Syndr. 2025 Feb 26. doi: 10.1097/QAI.0000000000003656.
    PubMed         Abstract available
    
    

    
    J Med Virol

24. JIANG Q, Zhou Z, Du X, Li Y, et al
    Novel Function of NUP153 in HNF4alpha Transcriptional Upregulation Contributes to Promoting HBV Replication.
    J Med Virol. 2025;97:e70256.
    PubMed         Abstract available
    
    

    
    J Virol

25. GOLAS G, Park BS, Wong SW
    Glycoproteins gM and gN are indispensable factors for rhesus macaque rhadinovirus replication and spread but can be reconstituted by KSHV chimeras.
    J Virol. 2025 Feb 25:e0192224. doi: 10.1128/jvi.01922.
    PubMed         Abstract available
    
    
26. GUERRERO JF, Zimdars LL, Bruce JW, Becker JT, et al
    Single-cell delineation of strain-specific HIV-1 Vif activities using dual reporter sensor cells and live cell imaging.
    J Virol. 2025 Feb 25:e0157924. doi: 10.1128/jvi.01579.
    PubMed         Abstract available
    
    

    
    JAMA

27. SEAS C, Seas PR, Legua P
    A 25-Year-Old With Verrucous Pustules and Fevers.
    JAMA. 2025 Feb 27. doi: 10.1001/jama.2024.28032.
    PubMed        
    
    
28. APPA A, Spinelli MA, Javanbakht M, Heise MJ, et al
    Unintentional Fentanyl Use Detected in Hair of People With HIV Risk Using Methamphetamine.
    JAMA. 2025 Feb 26:e2428618. doi: 10.1001/jama.2024.28618.
    PubMed        
    
    

    
    Lancet

29. DEVI S
    A new era for HIV in the Philippines?
    Lancet. 2025;405:611-612.
    PubMed        
    
    

    
    Nature

30. LI W, Qin Z, Nand E, Grunst MW, et al
    Author Correction: HIV-1 Env trimers asymmetrically engage CD4 receptors in membranes.
    Nature. 2025 Feb 24. doi: 10.1038/s41586-025-08802.
    PubMed        
    
    
31. STACEY JCV, Hrebik D, Nand E, Shetty SD, et al
    The conserved HIV-1 spacer peptide 2 triggers matrix lattice maturation.
    Nature. 2025 Feb 26. doi: 10.1038/s41586-025-08624.
    PubMed         Abstract available
    
    

    
    PLoS Comput Biol

32. TESLYA A, Heijne JCM, van der Loeff MFS, van Sighem A, et al
    Impact of increased diagnosis of early HIV infection and immediate antiretroviral treatment initiation on HIV transmission among men who have sex with men in the Netherlands.
    PLoS Comput Biol. 2025;21:e1012055.
    PubMed         Abstract available
    
    

    
    PLoS One

33. MISHRA SK, Senathilake KS, Kumar N, Patel CN, et al
    Exploratory algorithms to devise multi-epitope subunit vaccine by examining HIV-1 envelope glycoprotein: An immunoinformatics and viroinformatics approach.
    PLoS One. 2025;20:e0318523.
    PubMed         Abstract available
    
    
34. CHACHU KH, Maboe KA
    Viral suppression among patients in HIV/AIDS care at healthcare facilities in Ethiopia: Same-day antiretroviral initiation.
    PLoS One. 2025;20:e0309579.
    PubMed         Abstract available
    
    
35. O'BRIEN KK, Brown DA, McDuff K, St Clair-Sullivan N, et al
    Episodic disability framework in the context of Long COVID: Findings from a community-engaged international qualitative study.
    PLoS One. 2025;20:e0305187.
    PubMed         Abstract available
    
    
36. MADHURAVASAL KRISHNAN J, Kong L, Meeds HL, Roskin KM, et al
    The synthetic opioid fentanyl increases HIV replication in macrophages.
    PLoS One. 2025;20:e0298341.
    PubMed         Abstract available
    
    
37. BAZZI AR, Roth AM, Akiba CF, Huffaker SL, et al
    A systems analysis and improvement approach to optimizing syringe services programs' delivery of HIV testing and referrals: Study protocol for a parallel-group randomized controlled trial (SAIA-SSP-HIV).
    PLoS One. 2025;20:e0319340.
    PubMed         Abstract available
    
    
38. LEBLANC NM, Muheriwa-Matemba SR, St Vil N, Alcena-Stiner D, et al
    Couple-centered HIV prevention and care: Endorsement, practice and uncertainty among us healthcare providers in western-central upstate New York.
    PLoS One. 2025;20:e0299185.
    PubMed         Abstract available
    
    
39. D MUGAURI H, Mugurungi O, Chirenda J, Takarinda K, et al
    Integrating status-neutral and targeted HIV testing in Zimbabwe: A complementary strategy.
    PLoS One. 2025;20:e0302803.
    PubMed         Abstract available
    
    

    
    Virology

40. HOSSAIN MB, Tan BJY, Satou Y
    Viral oncogenesis of delta-retroviruses, HTLV-1 and BLV, and recent advances in its diagnosis.
    Virology. 2025;605:110461.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.